Literature DB >> 28821315

Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial.

Heather E Rasmussen1, Bruce Hamaker2, Kumar B Rajan3, Ece Mutlu4, Stefan J Green5, Michael Brown6, Amandeep Kaur7, Ali Keshavarzian8.   

Abstract

Approximately one-third of individuals in the United States experience unsatisfactory bowel habits, and dietary intake, especially one low in fiber, could be partly responsible. We hypothesized that intake of a fermentable fiber (starch-entrapped microspheres, SM) that has a delayed, slow fermentation profile in vitro would improve bowel habit while exhibiting prebiotic capacity in those with self-described unsatisfactory bowel habits, all with minimal adverse effects. A total of 43 healthy volunteers completed a 3-month, double-blind, parallel-arm randomized clinical trial to assess the ability of a daily dose (9 or 12 g) of SM vs psyllium (12 g) to improve bowel habit, including stool consistency and frequency, and modify gut milieu through changes in stool microbiota and short-chain fatty acids while remaining tolerable through minimal gastrointestinal symptoms. All outcomes were compared before and after fiber treatment. Stool frequency significantly improved (P=.0003) in all groups after 3 months, but stool consistency improved only in both SM groups compared with psyllium. In addition, all groups self-reported a similar improvement in overall bowel habit with fiber intake. Both SM and psyllium resulted in minimal changes in microbiota composition and short-chain fatty acid concentrations. The present study suggests that supplementation with a delayed and slow-fermenting fiber in vitro may improve bowel habit in those with constipation, but further investigation is warranted to determine capacity to alter microbiota and fermentation profiles in humans. This trial was registered at ClinicalTrials.gov as NCT01210625.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical trial; Constipation; Dietary fiber; Microbiota; Prebiotics

Mesh:

Substances:

Year:  2017        PMID: 28821315      PMCID: PMC5580357          DOI: 10.1016/j.nutres.2017.05.015

Source DB:  PubMed          Journal:  Nutr Res        ISSN: 0271-5317            Impact factor:   3.315


  36 in total

1.  Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB.

Authors:  T Z DeSantis; P Hugenholtz; N Larsen; M Rojas; E L Brodie; K Keller; T Huber; D Dalevi; P Hu; G L Andersen
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

2.  Guidelines--Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders.

Authors: 
Journal:  J Gastrointestin Liver Dis       Date:  2006-09       Impact factor: 2.008

3.  Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome.

Authors:  M Olesen; E Gudmand-Hoyer
Journal:  Am J Clin Nutr       Date:  2000-12       Impact factor: 7.045

4.  Massive parallel 16S rRNA gene pyrosequencing reveals highly diverse fecal bacterial and fungal communities in healthy dogs and cats.

Authors:  Stefanie Handl; Scot E Dowd; Jose F Garcia-Mazcorro; Jörg M Steiner; Jan S Suchodolski
Journal:  FEMS Microbiol Ecol       Date:  2011-02-14       Impact factor: 4.194

5.  In vitro batch fecal fermentation comparison of gas and short-chain fatty acid production using "slowly fermentable" dietary fibers.

Authors:  Amandeep Kaur; Devin J Rose; Pinthip Rumpagaporn; John A Patterson; Bruce R Hamaker
Journal:  J Food Sci       Date:  2011-04-27       Impact factor: 3.167

6.  Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation.

Authors:  W Ashraf; F Park; J Lof; E M Quigley
Journal:  Aliment Pharmacol Ther       Date:  1995-12       Impact factor: 8.171

7.  Primary structure of arabinoxylans of ispaghula husk and wheat bran.

Authors:  Sandra Edwards; Martin F Chaplin; Anne D Blackwood; Peter W Dettmar
Journal:  Proc Nutr Soc       Date:  2003-02       Impact factor: 6.297

Review 8.  Definitions, epidemiology, and impact of chronic constipation.

Authors:  Nicholas J Talley
Journal:  Rev Gastroenterol Disord       Date:  2004

9.  Degradation of polysaccharides by intestinal bacterial enzymes.

Authors:  A A Salyers; J K Palmer; T D Wilkins
Journal:  Am J Clin Nutr       Date:  1978-10       Impact factor: 7.045

Review 10.  Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health.

Authors:  David Ríos-Covián; Patricia Ruas-Madiedo; Abelardo Margolles; Miguel Gueimonde; Clara G de Los Reyes-Gavilán; Nuria Salazar
Journal:  Front Microbiol       Date:  2016-02-17       Impact factor: 5.640

View more
  3 in total

1.  Altered Intestinal Production of Volatile Fatty Acids in Dogs Triggered by Lactulose and Psyllium Treatment.

Authors:  Máté Mackei; Rebeka Talabér; Linda Müller; Ágnes Sterczer; Hedvig Fébel; Zsuzsanna Neogrády; Gábor Mátis
Journal:  Vet Sci       Date:  2022-04-23

2.  Improvement of bowel movements among people with a sedentary lifestyle after prebiotic snack supply - preliminary study.

Authors:  Ewa Stachowska; Dominika Maciejewska; Joanna Palma; Dominika Jamioł-Milc; Małgorzata Szczuko; Wojciech Marlicz; Ewa Wunsch; Karolina Skonieczna-Żydecka
Journal:  Prz Gastroenterol       Date:  2021-11-01

Review 3.  Nutraceuticals and Herbal Food Supplements for Weight Loss: Is There a Prebiotic Role in the Mechanism of Action?

Authors:  Alexander Bertuccioli; Marco Cardinali; Marco Biagi; Sara Moricoli; Ilaria Morganti; Giordano Bruno Zonzini; Giovanna Rigillo
Journal:  Microorganisms       Date:  2021-11-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.